Genix Pharmaceuticals (TSXV:GENX) Asset Impairment Charge : C$0.00 Mil (TTM As of Jan. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Genix Pharmaceuticals Asset Impairment Charge?

Genix Pharmaceuticals's Asset Impairment Charge for the three months ended in Jan. 2024 was C$0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.00 Mil.

Genix Pharmaceuticals Asset Impairment Charge Historical Data

The historical data trend for Genix Pharmaceuticals's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genix Pharmaceuticals Asset Impairment Charge Chart

Genix Pharmaceuticals Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Asset Impairment Charge

Get a 7-Day Free Trial

3.46

Genix Pharmaceuticals Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Genix Pharmaceuticals Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Genix Pharmaceuticals Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Genix Pharmaceuticals's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Genix Pharmaceuticals (TSXV:GENX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genix Pharmaceuticals Corp (TSXV:GENX) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

GENPF:USA

Address

1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8

Website

https://www.genixpharm.com

Genix Pharmaceuticals Corp is a Canadian life sciences company. It operates as a formulator, manufacturer, licensor, and marketer of life sciences related products with a focus on nutraceuticals and pharmaceuticals. Some of its products are Renochlor, Sucanon, and Flu-X. The company primarily operates in Canada.

Executives

Sina Pirooz

Director

Genix Pharmaceuticals (TSXV:GENX) Headlines

No Headlines